Einladung zum Lunch-Symposium

Use of endocannabinoid
receptor blocker
in daily clinical practice

Combination therapy
Dr. med. Jürg Lareida, Aarau

New clinical evidence for diabetic patients
PD Dr. med. Christoph Henzen, Luzern

Clinical experience in cardiometabolic
risk management

Donnerstag, 19. Juni 2008
13.15–14.00 h
KKL-Auditorium